I wanted toget everyone's thoughts on this matter:
Please correct me if I'm wrong or misguided.
This is how I understand the outcomes fromAsset Energy Vs The Commonwealth Minister for Resources:
1. The legal principles in question pertain toprocedural fairness. Scott Morrison's appointment is separate from this, butsupports our case very very well.
2. If there is a settlement, approval is notautomatically a given. Generally damages are awarded to make plaintiff (AdventEnergy) whole again in regards to money lost in the act of pursuing for therenewal of PEP-11.
Which is most likely the costs associated withmeeting NOPTAs administrative requirement, e.g environmental report and soforth.Effect of SharePrice
PEP-11 approval only effects the speculativevalue of BPH & BUY, however a settlement will have a very real and tangibleeffect on the value of BPH & BUY.
Below are my valuations for the share price based on the settlement value. The logic is straightforward. The settlement value is added to the current market cap and divided by the shares on issue. The only tricky party is that BPH owns 36% of Advent Energy and BUY owns 15%. Thus, the settlement values for BPH is 36% and BUY is 15%.
You can see that a $10 million settlement has a very small shift on the Share Price. I’ve chosen this value arbitrarily. Please note that I am unsure that the courts will consider opportunity costs. It seems unlikely, however anything could happen.
My question to you all is – What is the kind of settlementfigure should be awarded to Advent Energy? And will the court only consider theapplication costs in its damages or opportunity costs too?
- Forums
- ASX - By Stock
- BPH
- BPH - Scott Morrison's secrecy and lies exposed, PEP11 re-ignited
BPH - Scott Morrison's secrecy and lies exposed, PEP11 re-ignited, page-365
-
-
- There are more pages in this discussion • 182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BPH (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $15.82M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $7.367K | 566.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 5930690 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 478200 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 5730690 | 0.012 |
35 | 9275375 | 0.011 |
24 | 5403599 | 0.010 |
8 | 1379333 | 0.009 |
6 | 1900000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 478200 | 4 |
0.014 | 3015969 | 14 |
0.015 | 150000 | 2 |
0.016 | 104966 | 1 |
0.017 | 512880 | 2 |
Last trade - 12.29pm 12/11/2024 (20 minute delay) ? |
Featured News
BPH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online